logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Sympathomimetic Amine Anorectic class drugs

    FiltersReset Filters
    7 results

    • phendimetrazine tartrate

      (PHENDIMETRAZINE TARTRATE)
      Virtus Pharmaceuticals, LLC
      Usage: Phendimetrazine tartrate tablets are indicated for short-term management of exogenous obesity as an adjunct to caloric restriction weight reduction regimens. Their effectiveness should be weighed against potential risks associated with use.

    • phendimetrazine tartrate

      (PHENDIMETRAZINE TARTRATE)
      Acertis Pharmaceuticals, LLC
      Usage: Phendimetrazine tartrate extended-release capsules are indicated for the short-term management of exogenous obesity in patients with a BMI of ≥30 kg/m² or ≥27 kg/m² with associated risk factors, as an adjunct to caloric restriction for those unresponsive to diet and exercise alone.

    • phentermine hydrochloride

      (Phentermine Hydrochloride)
      Precision Dose Inc.
      Usage: Phentermine hydrochloride Tablets are used as a short-term adjunct to weight reduction programs, including exercise and caloric restriction, for managing exogenous obesity in patients with a BMI of ≥ 30 kg/m², or ≥ 27 kg/m² with additional risk factors like hypertension, diabetes, or hyperlipidemia.

    • phentermine hydrochloride

      (Phentermine Hydrochloride)
      TAGI Pharma, Inc
      Usage: Phentermine hydrochloride capsules are indicated for short-term weight reduction in conjunction with exercise, behavioral modification, and caloric restriction in patients with a body mass index (BMI) of ≥30 kg/m² or ≥27 kg/m² with risk factors like controlled hypertension or diabetes.

    • phentermine hydrochloride

      (Phentermine Hydrochloride)
      TAGI Pharma, Inc.
      Usage: Phentermine hydrochloride is indicated short-term for weight reduction in patients with a body mass index (BMI) of ≥30 kg/m² or ≥27 kg/m² with associated risk factors. It should support a regimen including exercise, behavioral modification, and caloric restriction in managing exogenous obesity.

    • phentermine hydrochloride

      (Phentermine Hydrochloride)
      Precision Dose Inc.
      Usage: Phentermine hydrochloride capsules are indicated for short-term weight reduction in adults with a BMI of 30 kg/m² or higher, or 27 kg/m² with additional risk factors like controlled hypertension, diabetes, or hyperlipidemia. It is recommended alongside exercise, behavioral modification, and caloric restriction.

    • qsymia

      (phentermine and topiramate)
      Vivus LLC
      Usage: QSYMIA is indicated for use alongside a reduced-calorie diet and increased physical activity to reduce body weight and maintain weight reduction in adults and pediatric patients (12+ years) with obesity, and adults with overweight plus at least one weight-related comorbidity.